1610736-83-8

Basic information

• Product Name: N-((1s,4s)-4-(2-(2'-((1,4-oxazepan-4-yl)methyl)-4'-hydroxybiphenyl-3-yloxy)-5-fluoronicotinamido)cyclohexyl)-5-methylimidazo[1,2-a]pyridine-2-carboxamide trifluoroacetic acid salt
• CAS NO: 1610736-83-8
• Molecular Weight: 806.814
• Mol File: 1610736-83-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-((1s,4s)-4-(2-(2'-((1,4-oxazepan-4-yl)methyl)-4'-hydroxybiphenyl-3-yloxy)-5-fluoronicotinamido)cyclohexyl)-5-methylimidazo[1,2-a]pyridine-2-carboxamide trifluoroacetic acid salt(CAS DataBase Reference)
• NIST Chemistry Reference: N-((1s,4s)-4-(2-(2'-((1,4-oxazepan-4-yl)methyl)-4'-hydroxybiphenyl-3-yloxy)-5-fluoronicotinamido)cyclohexyl)-5-methylimidazo[1,2-a]pyridine-2-carboxamide trifluoroacetic acid salt(1610736-83-8)
• EPA Substance Registry System: N-((1s,4s)-4-(2-(2'-((1,4-oxazepan-4-yl)methyl)-4'-hydroxybiphenyl-3-yloxy)-5-fluoronicotinamido)cyclohexyl)-5-methylimidazo[1,2-a]pyridine-2-carboxamide trifluoroacetic acid salt(1610736-83-8)

Safety Data

• Hazardous Substances Data: 1610736-83-8(Hazardous Substances Data)

Upstream product

• 1197291-02-3 tert-butyl (1s,4s)-4-(5-fluoro-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)nicotinamido)cyclohexylcarbamate 
• 582333-07-1 tert-butyl N-[(1s,4s)-4-(2-chloro-5-fluoronicotinamido)cyclohexyl]carbamate 
• 247570-24-7 tert-butyl N-[(1s,4s)-4-aminocyclohexyl]carbamate 
• 38186-88-8 2-chloro-5-fluoronicotinic acid 
• 1196806-69-5 tert-butyl N-[(1s,4s)-4-[5-fluoro-2-(3-iodophenoxy)nicotinamido]cyclohexyl]carbamate 
• 1197291-07-8 2-(2'-((1,4-oxazepan-4-yl)methyl)-4'-hydroxybiphenyl-3-yloxy)-N-((1s,4s)-4-aminocyclohexyl)-5-fluoronicotinamide 
• 88751-06-8 5-Methyl-imidazo[1,2-a]pyridine-2-carboxylic acid 
• 76-05-1 trifluoroacetic acid 
• 1197291-06-7 tert-butyl (1s,4s)-4-(2-(2'-((1,4-oxazepan-4-yl)methyl)-4'-hydroxybiphenyl-3-yloxy)-5-fluoronicotinamido)cyclohexylcarbamate 
• 1197291-03-4 tert-butyl (1s,4s)-4-(5-fluoro-2-(2'-formyl-4'-hydroxybiphenyl-3-yloxy)nicotinamido)cyclohexylcarbamate 

Relevant articles and documents

Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD

Oral phosphodiesterase 4 (PDE4) inhibitors, such as cilomilast and roflumilast, have been shown to be efficacious against chronic obstructive pulmonary disease (COPD). However, these drugs have been hampered by mechanism-related side effects such as nause